Free Trial

Integrated Quantitative Investments LLC Purchases New Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical logo with Medical background
Remove Ads

Integrated Quantitative Investments LLC purchased a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,000 shares of the medical instruments supplier's stock, valued at approximately $1,397,000. ICU Medical comprises about 0.7% of Integrated Quantitative Investments LLC's investment portfolio, making the stock its 19th largest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd purchased a new position in shares of ICU Medical during the 4th quarter worth $33,000. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical during the fourth quarter worth about $52,000. Venturi Wealth Management LLC boosted its holdings in ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares during the period. Smartleaf Asset Management LLC grew its holdings in ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock worth $140,000 after acquiring an additional 567 shares in the last quarter. Finally, Huntington National Bank boosted its position in shares of ICU Medical by 6.2% during the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock worth $218,000 after acquiring an additional 82 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several research analysts have commented on the company. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday, March 12th. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday, April 4th. Finally, Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $168.67.

Get Our Latest Research Report on ICUI

ICU Medical Stock Down 0.7 %

Shares of ICUI traded down $0.92 during midday trading on Wednesday, reaching $133.05. 54,533 shares of the company were exchanged, compared to its average volume of 256,504. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The stock has a 50-day moving average price of $149.63 and a 200-day moving average price of $161.69. The company has a market cap of $3.26 billion, a price-to-earnings ratio of -29.19 and a beta of 0.86.

ICU Medical Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Featured Stories

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Should You Invest $1,000 in ICU Medical Right Now?

Before you consider ICU Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.

While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads